Global Oral Contraceptive Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Report Code: KNJ918012 No. of Pages: 132 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Executive Summary
According to GRD Survey data, the global Oral Contraceptive market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.
This report studies the Oral Contraceptive market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Oral Contraceptive in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Combination
Progestin Only
Others
Market Snapshot, By Application
Male
Female
Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia
Main Market Players Analyzed in this report, including:
Teva Pharmaceutical Industries Ltd
Piramal Enterprises Ltd.
Pfizer, Inc.
Merck & Co., Inc.
Mankind Pharma Ltd.
Janssen Global Services, LLC
Beijing Zizhu Pharm
Bayer AG
Allergan, plc (Actavis)
The study objectives of this report are:
To study and analyze the global Oral Contraceptive market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Oral Contraceptive market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Oral Contraceptive manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oral Contraceptive market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Oral Contraceptive submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Oral Contraceptive are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Oral Contraceptive Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Oral Contraceptive Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Oral Contraceptive
3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Oral Contraceptive Sales Channel and Distributors Analysis
3.3.1 Oral Contraceptive Sales Channel
3.3.2 Oral Contraceptive Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Male
3.4.2 Major Buyers in Female
3.5 Oral Contraceptive Manufacturing Cost Structure Analysis
4 Market Segment: by Type
4.1 Oral Contraceptive Type Introduction
4.1.1 Combination
4.1.2 Progestin Only
4.1.3 Others
4.2 Global Oral Contraceptive Sales by Type 2016-2021
4.3 Global Oral Contraceptive Revenue by Type 2016-2021
4.4 Global Oral Contraceptive Price by Type 2016-2021
5 Market Segment: by Application
5.1 Oral Contraceptive Type Introduction
5.1.1 Male
5.1.2 Female
5.2 Global Oral Contraceptive Sales by Application 2016-2021
5.3 Global Oral Contraceptive Revenue by Application 2016-2021
5.4 Global Oral Contraceptive Price by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Oral Contraceptive Market by Region
6.1.1 Global Oral Contraceptive Sales by Regions
6.1.2 Global Oral Contraceptive Revenue by Regions
6.2 North America Oral Contraceptive Market 2016-2021
6.3 Europe Oral Contraceptive Market 2016-2021
6.4 Asia Pacific Oral Contraceptive Market 2016-2021
6.5 South America Oral Contraceptive Market 2016-2021
6.6 Middle East and Africa Oral Contraceptive Market 2016-2021
7 North America
7.1 North America Oral Contraceptive Market by Country 2016-2021
7.1.1 North America Oral Contraceptive Sales by Country
7.1.2 North America Oral Contraceptive Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Oral Contraceptive Market by Country 2016-2021
8.1.1 Europe Oral Contraceptive Sales by Country
8.1.2 Europe Oral Contraceptive Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Oral Contraceptive Market by Country 2016-2021
9.1.1 Asia Pacific Oral Contraceptive Sales by Country
9.1.2 Asia Pacific Oral Contraceptive Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Oral Contraceptive Market by Country 2016-2021
10.1.1 South America Oral Contraceptive Sales by Country
10.1.2 South America Oral Contraceptive Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Oral Contraceptive Market by Country 2016-2021
11.1.1 Middle East and Africa Oral Contraceptive Sales by Country
11.1.2 Middle East and Africa Oral Contraceptive Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Teva Pharmaceutical Industries Ltd
12.1.1 Teva Pharmaceutical Industries Ltd
Company Information
12.1.2 Teva Pharmaceutical Industries Ltd
Oral Contraceptive Product Portfolio, Specification and Application
12.1.3 Teva Pharmaceutical Industries Ltd
Oral Contraceptive Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Teva Pharmaceutical Industries Ltd
Key Development
12.2 Piramal Enterprises Ltd.
12.2.1 Piramal Enterprises Ltd.
Company Information
12.2.2 Piramal Enterprises Ltd.
Oral Contraceptive Product Portfolio, Specification and Application
12.2.3 Piramal Enterprises Ltd.
Oral Contraceptive Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Piramal Enterprises Ltd.
Key Development
12.3 Pfizer, Inc.
12.3.1 Pfizer, Inc.
Company Information
12.3.2 Pfizer, Inc.
Oral Contraceptive Product Portfolio, Specification and Application
12.3.3 Pfizer, Inc.
Oral Contraceptive Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Pfizer, Inc.
Key Development
12.4 Merck & Co., Inc.
12.4.1 Merck & Co., Inc.
Company Information
12.4.2 Merck & Co., Inc.
Oral Contraceptive Product Portfolio, Specification and Application
12.4.3 Merck & Co., Inc.
Oral Contraceptive Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Merck & Co., Inc.
Key Development
12.5 Mankind Pharma Ltd.
12.5.1 Mankind Pharma Ltd.
Company Information
12.5.2 Mankind Pharma Ltd.
Oral Contraceptive Product Portfolio, Specification and Application
12.5.3 Mankind Pharma Ltd.
Oral Contraceptive Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Mankind Pharma Ltd.
Key Development
12.6 Janssen Global Services, LLC
12.6.1 Janssen Global Services, LLC
Company Information
12.6.2 Janssen Global Services, LLC
Oral Contraceptive Product Portfolio, Specification and Application
12.6.3 Janssen Global Services, LLC
Oral Contraceptive Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Janssen Global Services, LLC
Key Development
12.7 Beijing Zizhu Pharm
12.7.1 Beijing Zizhu Pharm
Company Information
12.7.2 Beijing Zizhu Pharm
Oral Contraceptive Product Portfolio, Specification and Application
12.7.3 Beijing Zizhu Pharm
Oral Contraceptive Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Janssen Global Services, LLC
Key Development
12.9 Allergan, plc (Actavis)
12.9.1 Allergan, plc (Actavis)
Company Information
12.9.2 Allergan, plc (Actavis)
Oral Contraceptive Product Portfolio, Specification and Application
12.9.3 Allergan, plc (Actavis)
Oral Contraceptive Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Allergan, plc (Actavis)
Key Development
12.8.1 Bayer AG
Company Information
12.8.2 Bayer AG
Oral Contraceptive Product Portfolio, Specification and Application
12.8.3 Bayer AG
Oral Contraceptive Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Bayer AG
Key Development
13 Global Oral Contraceptive Market Forecast by Region by Type and by Application
13.1 Global Oral Contraceptive Sales, Revenue Forecast 2022-2027
13.2 Global Oral Contraceptive Forecast by Regions
13.2.1 Global Oral Contraceptive Sales Forecast by Region 2022-2027
13.2.2 Global Oral Contraceptive Revenue Forecast by Region 2022-2027
13.3 Global Oral Contraceptive Forecast by Type
13.3.1 Global Oral Contraceptive Sales Forecast by Type 2022-2027
13.3.2 Global Oral Contraceptive Revenue Forecast by Type 2022-2027
13.3.3 Global Oral Contraceptive Price Forecast by Type 2022-2027
13.4 Global Oral Contraceptive Forecast by Application
13.4.1 Global Oral Contraceptive Sales Forecast by Application 2022-2027
13.4.2 Global Oral Contraceptive Revenue Forecast by Application 2022-2027
13.4.3 Global Oral Contraceptive Price Forecast by Application 2022-2027
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com